ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 168 filers reported holding ABCELLERA BIOLOGICS INC in Q2 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,430,295 | -63.6% | 528,325 | -48.9% | 0.00% | -100.0% |
| Q2 2023 | $6,681,617 | +21.3% | 1,034,306 | +41.5% | 0.00% | 0.0% |
| Q1 2023 | $5,509,772 | -42.7% | 730,739 | -23.0% | 0.00% | -50.0% |
| Q4 2022 | $9,614,474 | -65.8% | 949,109 | -66.6% | 0.00% | -71.4% |
| Q3 2022 | $28,093,000 | +14.8% | 2,840,544 | +23.6% | 0.01% | +16.7% |
| Q2 2022 | $24,475,000 | +706.7% | 2,298,200 | +638.7% | 0.01% | – |
| Q1 2022 | $3,034,000 | -87.0% | 311,112 | -80.9% | 0.00% | – |
| Q4 2021 | $23,322,000 | -5.0% | 1,630,826 | +33.2% | 0.00% | -100.0% |
| Q3 2021 | $24,545,000 | +64.5% | 1,224,780 | +80.6% | 0.00% | +50.0% |
| Q2 2021 | $14,923,000 | +366.5% | 678,326 | +620.1% | 0.00% | – |
| Q1 2021 | $3,199,000 | +88.4% | 94,200 | +123.3% | 0.00% | – |
| Q4 2020 | $1,698,000 | – | 42,190 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $75,584,000 | 86.10% |
| Gruss & Co., LLC | 430,407 | $8,625,000 | 24.12% |
| SB Management Ltd | 9,817,190 | $196,736,000 | 20.16% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $76,767,000 | 7.97% |
| Intellectus Partners, LLC | 1,223,429 | $24,518,000 | 5.93% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $82,266,000 | 4.82% |
| ArchPoint Investors | 461,289 | $9,244,000 | 2.77% |
| Belmont Capital, LLC | 150,000 | $3,006,000 | 2.44% |
| CLOUGH CAPITAL PARTNERS L P | 971,297 | $19,465,000 | 1.18% |
| Orbimed Advisors | 4,180,768 | $83,783,000 | 0.92% |